nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefdinir—MPO—Octreotide—thymus cancer	0.912	1	CbGbCtD
Cefdinir—Hepatitis acute—Octreotide—thymus cancer	0.0191	0.228	CcSEcCtD
Cefdinir—Abnormal faeces—Octreotide—thymus cancer	0.00968	0.116	CcSEcCtD
Cefdinir—Peptic ulcer—Octreotide—thymus cancer	0.00414	0.0494	CcSEcCtD
Cefdinir—Cholestasis—Octreotide—thymus cancer	0.00364	0.0435	CcSEcCtD
Cefdinir—Coagulopathy—Octreotide—thymus cancer	0.00355	0.0424	CcSEcCtD
Cefdinir—Vaginal inflammation—Octreotide—thymus cancer	0.00277	0.033	CcSEcCtD
Cefdinir—Candida infection—Octreotide—thymus cancer	0.00264	0.0315	CcSEcCtD
Cefdinir—Vaginal infection—Octreotide—thymus cancer	0.00261	0.0312	CcSEcCtD
Cefdinir—Hyperkinesia—Octreotide—thymus cancer	0.00241	0.0288	CcSEcCtD
Cefdinir—Asthma—Octreotide—thymus cancer	0.00173	0.0207	CcSEcCtD
Cefdinir—Pneumonia—Octreotide—thymus cancer	0.00156	0.0186	CcSEcCtD
Cefdinir—Jaundice—Octreotide—thymus cancer	0.00151	0.018	CcSEcCtD
Cefdinir—Conjunctivitis—Octreotide—thymus cancer	0.0015	0.018	CcSEcCtD
Cefdinir—Haematuria—Octreotide—thymus cancer	0.00147	0.0176	CcSEcCtD
Cefdinir—Flatulence—Octreotide—thymus cancer	0.00119	0.0142	CcSEcCtD
Cefdinir—Agitation—Octreotide—thymus cancer	0.00111	0.0133	CcSEcCtD
Cefdinir—Loss of consciousness—Octreotide—thymus cancer	0.00106	0.0127	CcSEcCtD
Cefdinir—Convulsion—Octreotide—thymus cancer	0.00105	0.0125	CcSEcCtD
Cefdinir—Hypertension—Octreotide—thymus cancer	0.00104	0.0125	CcSEcCtD
Cefdinir—Chest pain—Octreotide—thymus cancer	0.00103	0.0123	CcSEcCtD
Cefdinir—Dry mouth—Octreotide—thymus cancer	0.00101	0.012	CcSEcCtD
Cefdinir—Anaphylactic shock—Octreotide—thymus cancer	0.000987	0.0118	CcSEcCtD
Cefdinir—Shock—Octreotide—thymus cancer	0.000971	0.0116	CcSEcCtD
Cefdinir—Thrombocytopenia—Octreotide—thymus cancer	0.000966	0.0115	CcSEcCtD
Cefdinir—Anorexia—Octreotide—thymus cancer	0.00094	0.0112	CcSEcCtD
Cefdinir—Insomnia—Octreotide—thymus cancer	0.000892	0.0107	CcSEcCtD
Cefdinir—Somnolence—Octreotide—thymus cancer	0.000877	0.0105	CcSEcCtD
Cefdinir—Dyspepsia—Octreotide—thymus cancer	0.000868	0.0104	CcSEcCtD
Cefdinir—Decreased appetite—Octreotide—thymus cancer	0.000858	0.0102	CcSEcCtD
Cefdinir—Gastrointestinal disorder—Octreotide—thymus cancer	0.000852	0.0102	CcSEcCtD
Cefdinir—Constipation—Octreotide—thymus cancer	0.000844	0.0101	CcSEcCtD
Cefdinir—Gastrointestinal pain—Octreotide—thymus cancer	0.000807	0.00964	CcSEcCtD
Cefdinir—Abdominal pain—Octreotide—thymus cancer	0.00078	0.00932	CcSEcCtD
Cefdinir—Body temperature increased—Octreotide—thymus cancer	0.00078	0.00932	CcSEcCtD
Cefdinir—Hypersensitivity—Octreotide—thymus cancer	0.000727	0.00868	CcSEcCtD
Cefdinir—Asthenia—Octreotide—thymus cancer	0.000708	0.00846	CcSEcCtD
Cefdinir—Pruritus—Octreotide—thymus cancer	0.000698	0.00834	CcSEcCtD
Cefdinir—Diarrhoea—Octreotide—thymus cancer	0.000675	0.00806	CcSEcCtD
Cefdinir—Dizziness—Octreotide—thymus cancer	0.000652	0.00779	CcSEcCtD
Cefdinir—Vomiting—Octreotide—thymus cancer	0.000627	0.00749	CcSEcCtD
Cefdinir—Rash—Octreotide—thymus cancer	0.000622	0.00743	CcSEcCtD
Cefdinir—Dermatitis—Octreotide—thymus cancer	0.000622	0.00742	CcSEcCtD
Cefdinir—Headache—Octreotide—thymus cancer	0.000618	0.00738	CcSEcCtD
Cefdinir—Nausea—Octreotide—thymus cancer	0.000586	0.007	CcSEcCtD
Cefdinir—SLC15A1—epithelium—thymus cancer	0.00043	0.107	CbGeAlD
Cefdinir—MPO—hematopoietic system—thymus cancer	0.000423	0.105	CbGeAlD
Cefdinir—MPO—epithelium—thymus cancer	0.000387	0.096	CbGeAlD
Cefdinir—MPO—pituitary gland—thymus cancer	0.000314	0.0779	CbGeAlD
Cefdinir—MPO—lymphoid tissue—thymus cancer	0.000298	0.0739	CbGeAlD
Cefdinir—MPO—bone marrow—thymus cancer	0.000271	0.0673	CbGeAlD
Cefdinir—MPO—lung—thymus cancer	0.000246	0.061	CbGeAlD
Cefdinir—SLC15A2—pituitary gland—thymus cancer	0.000218	0.0541	CbGeAlD
Cefdinir—SLC22A5—cardiac atrium—thymus cancer	0.000194	0.0482	CbGeAlD
Cefdinir—SLC22A5—pituitary gland—thymus cancer	0.00019	0.0471	CbGeAlD
Cefdinir—SLC15A2—thyroid gland—thymus cancer	0.000188	0.0467	CbGeAlD
Cefdinir—SLC15A2—lung—thymus cancer	0.000171	0.0424	CbGeAlD
Cefdinir—MPO—lymph node—thymus cancer	0.000168	0.0417	CbGeAlD
Cefdinir—SLC22A5—thyroid gland—thymus cancer	0.000164	0.0406	CbGeAlD
Cefdinir—SLC22A5—lung—thymus cancer	0.000149	0.0369	CbGeAlD
Cefdinir—SLC15A2—lymph node—thymus cancer	0.000117	0.029	CbGeAlD
Cefdinir—SLC22A5—lymph node—thymus cancer	0.000102	0.0252	CbGeAlD
